-
-
Anti-PDGFRB / CD140b Reference Antibody (rinucumab),, 50 микрограмм
-
Anti-PGLYRP1 / PGRP-S Reference Antibody (Novo Nordisk patent anti-PGLYRP1),, 50 микрограмм
-
Anti-PDGFRB / CD140b Reference Antibody (IMC-2C5),, 50 микрограмм
-
Anti-PDGFRA / CD140a Reference Antibody (olaratumab),, 50 микрограмм
-
Anti-PDGFRA / CD140a Reference Antibody (tovetumab),, 50 микрограмм
-
Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics patent anti-PDGF-C),, 50 микрограмм
-
Anti-PDGFB Reference Antibody (MOR-8457),, 50 микрограмм
-
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (UCB patent anti-PD-1),, 50 микрограмм
-
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (zimberelimab),, 50 микрограмм
-
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (toripalimab),, 50 микрограмм
-
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab),, 50 микрограмм
стр.: